Stefan Glombitza
Chief Executive Officer at FORMYCON AG
Profile
Stefan Glombitza is currently the Chief Executive Officer at Formycon AG since 2022.
Previously, he worked at Hexal AG as a Manager-Medical Affairs and at Hexal Pharmaforschung GmbH as the Head-Project Management.
Dr. Glombitza holds a doctorate degree from the University of Regensburg.
Stefan Glombitza active positions
| Companies | Position | Start |
|---|---|---|
| FORMYCON AG | Chief Executive Officer | 2022-06-30 |
Former positions of Stefan Glombitza
| Companies | Position | End |
|---|---|---|
| Hexal Pharmaforschung GmbH | Corporate Officer/Principal | - |
Hexal AG
 Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Corporate Officer/Principal | - |
Training of Stefan Glombitza
| University of Regensburg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| FORMYCON AG | Health Technology |
| Private companies | 2 |
|---|---|
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Health Technology |
| Hexal Pharmaforschung GmbH |
- Stock Market
- Insiders
- Stefan Glombitza
